K. Ishiyama

Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report

M. Imamura, K. Chayama, H. Ohdan, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation

M. Imamura, N. Hiraga, K. Chayama, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation

M. Imamura, K. Chayama, H. Ohdan, 2017, Clinical Journal of Gastroenterology.

Involvement of tumor necrosis factor-a receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-( TRAIL ) receptor-2 / DR-5 , but not Fas , in graft injury in live-donor liver trans plantation

T. Asahara, H. Ohdan, K. Sugino, 2005 .

Involvement of tumor necrosis factor-α receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation

T. Asahara, H. Ohdan, K. Sugino, 2004 .

Vascular closure staples for portal vein reconstruction in living-donor liver transplantation.

T. Asahara, H. Ohdan, H. Hara, 2005, American journal of surgery.

Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation

H. Ohdan, A. Oshita, Yuka Tanaka, 2013, Transplantation.

Memory-like Liver Natural Killer Cells are Responsible for Islet Destruction in Secondary Islet Transplantation

H. Ohdan, Y. Saeki, K. Ishiyama, 2019, Scientific Reports.